(Q48380925)

11 February 2018

title

Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. (English)

1 reference

11 February 2018

1 reference

5

Nancy U Lin

1 reference

11 February 2018

author name string

Nils D Arvold

1

1 reference

11 February 2018

Kevin S Oh

2

1 reference

11 February 2018

Andrzej Niemierko

3

1 reference

11 February 2018

Alphonse G Taghian

4

1 reference

11 February 2018

Rita F Abi-Raad

6

1 reference

11 February 2018

Meera Sreedhara

7

1 reference

11 February 2018

Jay R Harris

8

1 reference

11 February 2018

Brian M Alexander

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

12 September 2012

1 reference

11 February 2018

Breast Cancer Research and Treatment

published in

1 reference

11 February 2018

volume

136

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

153-160

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s10549-012-2243-x

exact match

0 references

cites work

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

CNS metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Breast cancer subtypes and survival in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Metastatic behavior of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2243-X

10.1007/S10549-012-2243-X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22968656

1 reference

11 February 2018